122 related articles for article (PubMed ID: 6931471)
1. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. II. Factor analysis of the CPRS sub-scale for schizophrenia.
Dencker SJ; Frankenberg K; Hansen V; Malm U
Acta Psychiatr Scand Suppl; 1980; 279():29-40. PubMed ID: 6931471
[TBL] [Abstract][Full Text] [Related]
2. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate.
Dencker SJ; Lepp M; Malm U
Acta Psychiatr Scand Suppl; 1980; 279():10-28. PubMed ID: 6931470
[TBL] [Abstract][Full Text] [Related]
3. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. IV. Serum levels and clinical outcome.
Dencker SJ; Malm U; Jørgensen A; Overø KF
Acta Psychiatr Scand Suppl; 1980; 279():55-63. PubMed ID: 6931473
[TBL] [Abstract][Full Text] [Related]
4. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.
Jrgensen A; Overø KF
Acta Psychiatr Scand Suppl; 1980; 279():41-54. PubMed ID: 6931472
[TBL] [Abstract][Full Text] [Related]
5. Aspects of clinical psychiatric research on depot neuroleptics. The presentation of two double-blind trials with cis(z)-clopenthixol decanoate and a withdrawal study in schizophrenics.
Dencker SJ; Elgen K
Acta Psychiatr Scand Suppl; 1980; 279():5-9. PubMed ID: 6996425
[No Abstract] [Full Text] [Related]
6. Do schizophrenics well adapted in the community need neuroleptics? A depot neuroleptic withdrawal study.
Dencker SJ; Lepp M; Malm U
Acta Psychiatr Scand Suppl; 1980; 279():64-76. PubMed ID: 6105763
[TBL] [Abstract][Full Text] [Related]
7. Maintenance treatment of chronic schizophrenic patients. A study with the long-acting thioxanthene derivative, cis(Z)-clopenthixol decanoate-sordinol depot.
Dom R; De Mesmaecker L; van den Broucke M; van Hest T; Baro F
Acta Psychiatr Scand; 1978 Apr; 57(4):299-304. PubMed ID: 352094
[TBL] [Abstract][Full Text] [Related]
8. The positive and negative symptoms of schizophrenia: patterns of response to depot neuroleptic treatment.
Martyns-Yellowe IS
West Afr J Med; 1994; 13(4):200-3. PubMed ID: 7756183
[TBL] [Abstract][Full Text] [Related]
9. Depot neuroleptics in a community mental health service.
Blake B
Br Med J; 1979 Jul; 2(6181):48-9. PubMed ID: 466266
[No Abstract] [Full Text] [Related]
10. [Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
Eufe R; Wegener G
Nervenarzt; 1979 Aug; 50(8):534-9. PubMed ID: 394015
[No Abstract] [Full Text] [Related]
11. A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
Pinto R; Bannerjee A; Ghosh N
Acta Psychiatr Scand; 1979 Oct; 60(4):313-22. PubMed ID: 390972
[TBL] [Abstract][Full Text] [Related]
12. Schizophrenic relapse after drug withdrawal is predictable.
Dencker SJ; Malm U; Lepp M
Acta Psychiatr Scand; 1986 Feb; 73(2):181-5. PubMed ID: 3705994
[TBL] [Abstract][Full Text] [Related]
13. A comparative trial of depot pipothiazine.
Steinert J; Neder A; Erba E; Pugh CR; Robinson C; Priest RG
J Int Med Res; 1986; 14(2):72-7. PubMed ID: 2870944
[TBL] [Abstract][Full Text] [Related]
14. [Dose and serum drug level and its clinical effects during the long-term treatment of chronic schizophrenia with flupenthixol depot].
Lipska B; Szukalski B; Nurowska K; Welbel L
Psychiatr Pol; 1986; 20(1):1-7. PubMed ID: 3725983
[No Abstract] [Full Text] [Related]
15. Long-term treatment of chronic schizophrenics with clopenthixol decanoate.
Borsetti G; Rocco P; Spilimbergo PG; Giavedoni A; Frangiamone L; Beccaceci A; Judice A; Cisternino M; Volterra V
Pharmatherapeutica; 1984; 4(1):53-6. PubMed ID: 6150492
[TBL] [Abstract][Full Text] [Related]
16. [cis(Z)-Clopenthixol decanoate--a new depot neuroleptic].
Sieberns S; Spechtmeyer H
Int Pharmacopsychiatry; 1982; 17(3):170-84. PubMed ID: 7141812
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia.
Carney MW; Sheffield BF
Br J Psychiatry; 1976 Nov; 129():476-81. PubMed ID: 990663
[TBL] [Abstract][Full Text] [Related]
18. Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia.
Kelly HB; Freeman HL; Banning B; Schiff AA
Int Pharmacopsychiatry; 1977; 12(1):54-64. PubMed ID: 406212
[TBL] [Abstract][Full Text] [Related]
19. A 5-year follow-up study of chronic schizophrenics treated with clopenthixol decanoate.
Carney MW
Pharmatherapeutica; 1984; 4(1):57-63. PubMed ID: 6150493
[TBL] [Abstract][Full Text] [Related]
20. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.
Ahlfors UG; Dencker SJ; Gravem A; Remvig J
Acta Psychiatr Scand Suppl; 1980; 279():77-91. PubMed ID: 6996426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
